ARCHIVES

ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Eight Scientists Receive $800,000 From Milken

January 12, 1990

ASCO, Komen Begin Initiative To Address Cancer Care Disparities.

October 31, 2008

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

Mammography Quality Standards Set, FDA User Fees Enacted; Oral Cancer Drugs Covered

October 16, 1992

Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.

July 11, 2008